<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Invitrogen from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Invitrogen news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 08:11:08 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Invitrogen" rel="self" type="application/rss+xml" />

	
<item><title>S.D. Companies Race to Build Gene Machines</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031278&amp;HITNO=0&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031278&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534116633%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031278&amp;HITNO=0&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031278&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534116633%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Diego Business Journal:</description></item>
<item><title>ISCO stem cell production site passes building inspection</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029322&amp;HITNO=1&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029322&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533088894%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029322&amp;HITNO=1&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029322&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533088894%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>In-Pharmatechnologist:</description></item>
<item><title>Genetics Researcher Ready For Prime Time</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024150&amp;HITNO=2&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024150&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528667934%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024150&amp;HITNO=2&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024150&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528667934%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Life Technologies Completes Divestiture of Mass Spectrometry Business</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991928&amp;HITNO=3&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991928&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513926644%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991928&amp;HITNO=3&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991928&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513926644%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Life Technologies Earns $145M in the Year of H1N1</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985633&amp;HITNO=4&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508713980%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3985633&amp;HITNO=4&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3985633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508713980%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Diego Business Journal:</description></item>
<item><title>Life Tech Mass Spec Revenues Up 14 Percent in Q4 2009</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977235&amp;HITNO=5&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977235&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504724846%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977235&amp;HITNO=5&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977235&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504724846%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>Life Technologies collaborating with Ignite Institute on genomic sequencing center</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976692&amp;HITNO=6&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976692&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504461452%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976692&amp;HITNO=6&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976692&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504461452%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DCExaminer.com:</description></item>
<item><title>Life Technologies partners on genomic center</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976598&amp;HITNO=7&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976598&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504425385%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976598&amp;HITNO=7&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976598&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504425385%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Forbes.com:</description></item>
<item><title>Latest Trends in Stem Cell Technologies</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3955120&amp;HITNO=8&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3955120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493736683%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3955120&amp;HITNO=8&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3955120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493736683%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Labmate Online:</description></item>
<item><title>Genomics Lawsuit Spurs Drama</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3957223&amp;HITNO=9&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3957223&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2494881158%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3957223&amp;HITNO=9&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3957223&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2494881158%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Forbes.com:</description></item>
<item><title>Lucifer at it again! Life Tech Denies Breach-of-Contract Claims in Suit by Former Visigen CEO</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933533&amp;HITNO=10&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933533&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481766465%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933533&amp;HITNO=10&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933533&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481766465%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioFind:</description></item>
<item><title>Life Tech Denies Breach-of-Contract Claims in Suit by Former Visigen CEO</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932399&amp;HITNO=11&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932399&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481092497%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932399&amp;HITNO=11&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932399&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481092497%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>Life Technologies Denies Allegations Made by Former Visigen CEO</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937238&amp;HITNO=12&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937238&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483428470%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937238&amp;HITNO=12&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937238&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483428470%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>GEN's ELISA REDUX Cryptogram Solved</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3919086&amp;HITNO=13&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3919086&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2473188036%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3919086&amp;HITNO=13&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3919086&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2473188036%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>VisiGen Founder Sues Life Technologies for Fraud</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3912063&amp;HITNO=14&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3912063&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470037030%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3912063&amp;HITNO=14&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Invitrogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3912063&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470037030%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Bio-IT World:</description></item>
</channel></rss>